Antimicrobial peptides based on CMAP27

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9006174
APP PUB NO 20120093844A1
SERIAL NO

13201070

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention concerns derivatives of CMAP27, which have a good antimicrobial activity and a low haemolytic activity as compared to the wild-type CMAP27 peptide. These derivatives can be used for antibiotic therapy or in a bacteriocidal composition. Further comprised in the invention is the use of CMAP27 and/or its derivatives as adjuvant.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITEIT UTRECHT HOLDING B VYALELAAN 40 UTRECHT 3584 CM

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bikker, Floris Jacob Gouda, NL 7 48
Haagsman, Hendrik Zeist, NL 3 0
Mars-Groenendijk, Rosalia Nootdorp, NL 3 0
Molhoek, Elisabeth Margaretha Rotterdam, NL 3 0
Van, Der Kleij Desiree Zoetermeer, NL 3 0
Van, Dijk Albert Zeist, NL 9 2
Veldhuizen, Edwin Johannes Adrianus Utrecht, NL 8 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 14, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00